Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Generated: April 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020411

« Back to Dashboard

NDA 020411 describes CERVIDIL, which is a drug marketed by Ferring Pharms Inc and is included in one NDA. It is available from one supplier. Additional details are available on the CERVIDIL profile page.

The generic ingredient in CERVIDIL is dinoprostone. There are four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the dinoprostone profile page.

Summary for 020411

Tradename:	CERVIDIL
Applicant:	Ferring Pharms Inc
Ingredient:	dinoprostone
Patents:	0
Therapeutic Class:	Hormonal Agents, Stimulant/Replacement/Modifying (Prostaglandins)
Formulation / Manufacturing:	see details

Pharmacology for NDA: 020411

Ingredient-type	Prostaglandins

Medical Subject Heading (MeSH) Categories for 020411

Oxytocics

Suppliers and Packaging for NDA: 020411

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
CERVIDIL	dinoprostone	INSERT, EXTENDED RELEASE;VAGINAL	020411	NDA	Ferring Pharmaceuticals Inc.	55566-2800	N	55566-2800-1
CERVIDIL	dinoprostone	INSERT, EXTENDED RELEASE;VAGINAL	020411	NDA	Ferring Pharmaceuticals Inc.	55566-9500	N	55566-9500-1

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	INSERT, EXTENDED RELEASE;VAGINAL			Strength	10MG
Approval Date:	Mar 30, 1995	TE:		RLD:	Yes

Expired US Patents for NDA 020411

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Ferring Pharms Inc	CERVIDIL	dinoprostone	INSERT, EXTENDED RELEASE;VAGINAL	020411-001	Mar 30, 1995	➤ Sign Up	➤ Sign Up
Ferring Pharms Inc	CERVIDIL	dinoprostone	INSERT, EXTENDED RELEASE;VAGINAL	020411-001	Mar 30, 1995	➤ Sign Up	➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.